197 related articles for article (PubMed ID: 8228579)
1. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
[TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin.
Rauch J; Tannenbaum M; Neville C; Fortin PR
Thromb Haemost; 1998 Dec; 80(6):936-41. PubMed ID: 9869164
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease.
Drouvalakis KA; Buchanan RR
J Rheumatol; 1998 Feb; 25(2):290-5. PubMed ID: 9489821
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
7. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
Mcintyre JA; Wagenknecht DR
J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-phosphatidylethanolamine antibodies using flow cytometry.
Drouvalakis KA; Neeson PJ; Buchanan RR
Cytometry; 1999 May; 36(1):46-51. PubMed ID: 10331626
[TBL] [Abstract][Full Text] [Related]
11. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
12. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
[TBL] [Abstract][Full Text] [Related]
13. [Lupus anticoagulants versus antiphospholipid antibodies].
Pereira MI
Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
[TBL] [Abstract][Full Text] [Related]
14. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus.
Karmochkine M; Berard M; Piette JC; Cacoub P; Aillaud MF; Harlé JR; Godeau P; Boffa MC; Harlet JR
Lupus; 1993 Jun; 2(3):157-60. PubMed ID: 8369806
[TBL] [Abstract][Full Text] [Related]
15. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
Boffa MC; Berard M; Sugi T; McIntyre JA
J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
Kandiah DA; Krilis SA
Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
[TBL] [Abstract][Full Text] [Related]
17. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance].
Wisløff F; Sletnes KE; Schjetlein R
Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396
[TBL] [Abstract][Full Text] [Related]
18. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.
Berard M; Chantome R; Marcelli A; Boffa MC
J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
